NO20044413L - 1,2-Dihydropyrazol-3-oner som cytokinmediatorer - Google Patents

1,2-Dihydropyrazol-3-oner som cytokinmediatorer

Info

Publication number
NO20044413L
NO20044413L NO20044413A NO20044413A NO20044413L NO 20044413 L NO20044413 L NO 20044413L NO 20044413 A NO20044413 A NO 20044413A NO 20044413 A NO20044413 A NO 20044413A NO 20044413 L NO20044413 L NO 20044413L
Authority
NO
Norway
Prior art keywords
dihydropyrazol
ones
cytokine mediators
mediators
cytokine
Prior art date
Application number
NO20044413A
Other languages
English (en)
Inventor
Biswanath De
Matthew John Laufersweiler
Michael Phillip Clark
Jane Far-Jine Djung
Michael George Natchus
Cynthia Monesa Crago
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20044413L publication Critical patent/NO20044413L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20044413A 2002-03-19 2004-10-18 1,2-Dihydropyrazol-3-oner som cytokinmediatorer NO20044413L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36570102P 2002-03-19 2002-03-19
PCT/US2003/007635 WO2003080184A1 (en) 2002-03-19 2003-03-12 1,2-dihydropyrazol-3-ones as cytokine mediators

Publications (1)

Publication Number Publication Date
NO20044413L true NO20044413L (no) 2004-10-18

Family

ID=28454704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044413A NO20044413L (no) 2002-03-19 2004-10-18 1,2-Dihydropyrazol-3-oner som cytokinmediatorer

Country Status (22)

Country Link
US (1) US6677337B2 (no)
EP (1) EP1485167A1 (no)
JP (1) JP2006502093A (no)
KR (1) KR20040093158A (no)
CN (1) CN1642600A (no)
AR (1) AR039001A1 (no)
AU (1) AU2003220216A1 (no)
BR (1) BR0308579A (no)
CA (1) CA2477091A1 (no)
CO (1) CO5611175A2 (no)
IL (1) IL163712A0 (no)
MA (1) MA27784A1 (no)
MX (1) MXPA04009088A (no)
MY (1) MY134226A (no)
NO (1) NO20044413L (no)
NZ (1) NZ534869A (no)
PE (1) PE20040160A1 (no)
PL (1) PL372882A1 (no)
RU (1) RU2004130843A (no)
TW (1) TW200306182A (no)
WO (1) WO2003080184A1 (no)
ZA (1) ZA200407135B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
PL379544A1 (pl) * 2002-09-09 2006-10-02 Amgen Inc. 1,4,5-podstawione pochodne 1,2-dihydro-pirazol-3-onu i 3-alkoksy 1H-pirazolu jako środki obniżające poziom TNF-alfa oraz interleukin do leczenia stanów zapalnych
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
CA2587427A1 (en) * 2004-11-17 2006-05-26 Miikana Therapeutics, Inc. Kinase inhibitors
JP5178515B2 (ja) 2005-08-12 2013-04-10 シンタ ファーマシューティカルズ コーポレーション Hsp90活性を調節するピラゾール化合物
ES2535854T3 (es) * 2005-09-30 2015-05-18 Miikana Therapeutics, Inc. Compuestos de pirazol sustituidos
US20090029992A1 (en) * 2007-06-11 2009-01-29 Agoston Gregory E Substituted pyrazole compounds
WO2018192793A1 (en) 2017-04-20 2018-10-25 Basf Se Substituted rhodanine derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663327A (en) * 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
US5559137A (en) * 1994-05-16 1996-09-24 Smithkline Beecham Corp. Compounds
AU2002228783A1 (en) * 2000-12-05 2002-06-18 Vertex Pharmaceuticals Incorporated Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
CA2446864C (en) * 2001-05-16 2011-02-15 Vertex Pharmaceuticals Incorporated Inhibitors of src and other protein kinases
US6566357B1 (en) * 2001-09-20 2003-05-20 The Procter & Gamble Co. Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
AR039001A1 (es) 2005-02-02
RU2004130843A (ru) 2005-08-27
PL372882A1 (en) 2005-08-08
KR20040093158A (ko) 2004-11-04
WO2003080184A1 (en) 2003-10-02
AU2003220216A1 (en) 2003-10-08
CA2477091A1 (en) 2003-10-02
CN1642600A (zh) 2005-07-20
MA27784A1 (fr) 2006-03-01
MXPA04009088A (es) 2004-12-06
TW200306182A (en) 2003-11-16
ZA200407135B (en) 2005-09-21
US6677337B2 (en) 2004-01-13
PE20040160A1 (es) 2004-04-30
IL163712A0 (en) 2005-12-18
CO5611175A2 (es) 2006-02-28
JP2006502093A (ja) 2006-01-19
EP1485167A1 (en) 2004-12-15
MY134226A (en) 2007-11-30
BR0308579A (pt) 2005-01-25
US20030225082A1 (en) 2003-12-04
NZ534869A (en) 2006-09-29

Similar Documents

Publication Publication Date Title
CY2014041I1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
NO20053248D0 (no) Kerosenblanding.
IS7547A (is) Ónæmisvaldandi samsetningar
NO20052248D0 (no) Svivelstykkesystem.
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
NO20051500D0 (no) Substituerte heterocyklylpyrimidiner.
ATE419254T1 (de) 5-ää(2,3-difluorophenyl)methylüthioü-7-ää2- hydroxy-1-(hydroxymethyl)-1-
BR0300119B1 (pt) composiÇço aquosa.
DK1492934T3 (da) Dørenhed
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
NO20051497D0 (no) Beta-laktamaseinhibitorprodrug.
NO20044413L (no) 1,2-Dihydropyrazol-3-oner som cytokinmediatorer
ITMI20032170A1 (it) Tagliacimosse.
NO20044405L (no) Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
SE0301847D0 (sv) Novel 3,3-Diphenylpropylamines
DK1381609T3 (da) 5-Halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidiner som fungicider
ITTO20020077A0 (it) Cronice artistica di arredo.
ES1051703Y (es) Potera.
ES1051605Y (es) Cromo-puzzle.
ES1051110Y (es) Caja-palet.
ES1052029Y (es) Balin-proyectil.
ES1052654Y (es) Cubitera.